Keyword: cell and gene therapy


RoslinCT to Join Manufacturing Network for CRISPR-Based Therapy

04.12.2023 -

UK’s RoslinCT, a cell and gene therapy contract development and manufacturing organization, will be part of the Vertex Pharmaceuticals global network producing the CRISPR...


AstraZeneca Acquires Early-stage Gene Therapies from Pfizer

31.07.2023 -

Alexion, AstraZeneca's rare disease division, has agreed to buy a portfolio of preclinical gene therapy programs and enabling technologies from competitor Pfizer for up...


Siegfried Takes Majority Stake in Dinamiqs

09.05.2023 -

Swiss CDMO Siegfried has acquired a 95% stake in Dinamiqs, a compatriot biotech focused on developing and manufacturing viral vectors for cell and gene therapies.


Vertex Buys ViaCyte for $320 Million

19.07.2022 -

US-based Vertex Pharmaceuticals has agreed to pay $320 million in cash to acquire ViaCyte, a compatriot private cellular therapy company specializing in a treatment for...


Solvias Boosts Testing Services with Cergentis Buy

18.07.2022 -

Solvias, a Swiss CDMO serving the pharmaceutical, biotechnology, material science and cosmetic industries, has acquired Dutch biotech Cergentis for an undisclosed sum...

Markets & Companies

Ramping Up Biomanufacturing Capacity

20.04.2022 -

Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...


Catalent to Acquire Delphi Genetics

25.02.2021 -

Leading US gene therapy CDMO Catalent is buying all shares of another CDMO in the same field, plasmid DNA (pDNA) specialist’s Delphi Genetics, headquartered at Gosselie...


GSK and Miltenyi Biotec in Cell and Gene Therapy Pact

22.03.2016 - Britain’s largest pharmaceutical company, Glaxo SmithKline (GSK), has formed a strategic collaboration with German biotechnology firm Miltenyi Biotec to develop cell and gene...